Physician
Martin, Alvin
Martin, Alvin was paid $21K by Medicaid between Mar 2022 and Mar 2022, across 22 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 21% of everything it billed.
33Billing provider infoMARTIN, ALVIN
LOUISVILLE, KY 40220
LOUISVILLE, KY 40220
33aNPI1124005814assigned 12/23/2005
33bProvider typeHematology (Pathology) Physician
28Total paid$21K
24GClaims761
24DCodes billed22
24AFirst – last monthMar 2022 – Mar 2022
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 761 | $21K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 21% | 30 | 30 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10% | 63 | 61 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 10% | 63 | 61 | $2K |
| 81513 | 9.7% | 26 | 26 | $2K | |
| 87481 | 8.5% | 52 | 26 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 8.4% | 15 | 15 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 8.0% | 49 | 48 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.7% | 36 | 35 | $772.48 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.7% | 105 | 102 | $755.75 |
| 84443 | Thyroid stimulating hormone (TSH) | 2.8% | 35 | 35 | $574.73 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.7% | 21 | 20 | $565.38 |
| 80053 | Comprehensive metabolic panel | 1.8% | 40 | 39 | $376.39 |
10 more codes
| 86803 | 1.7% | 28 | $357.60 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.7% | 44 | $347.89 |
| 86780 | 1.4% | 23 | $279.09 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 21 | $175.08 |
| 87340 | <1% | 19 | $165.58 | |
| 80061 | Lipid panel | <1% | 13 | $154.93 |
| 84439 | <1% | 18 | $154.78 | |
| 87186 | <1% | 12 | $104.15 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 34 | $80.15 |
| 85652 | <1% | 14 | $35.19 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.